These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6421083)

  • 101. Estrogen treatment of postmenopausal vaginal atrophy--a cytological assessment.
    Hustin J; Drykoningen GJ
    Maturitas; 1979 Feb; 1(3):207-13. PubMed ID: 502878
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Clinical, cytological and biological study of the intra-vaginal administration of oestriol (Ortho-Gynest) in post-menopausal patients.
    Wesel S; Etienne J; Lestienne MC
    Maturitas; 1981 Dec; 3(3-4):271-7. PubMed ID: 7334936
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Terconazole cream and suppositories: plasma terconazole following vaginal administration.
    Kennedy BK; Friedmann N
    Gynakol Rundsch; 1985; 25 Suppl 1():26-32. PubMed ID: 4007621
    [No Abstract]   [Full Text] [Related]  

  • 104. The effect of various doses of oral oestradiolvalerate and oestriolsuccinate on urine calcium/creatinine, serum FSH and endometrium in castrated women.
    Rauramo L; Punnonen R; Lauslahti K; Grönroos M
    Acta Obstet Gynecol Scand; 1977; 56(4):363-8. PubMed ID: 602704
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Oestriol in the control of postmenopausal symptoms. Preliminary report of a clinical trial.
    Wren BG
    Med J Aust; 1982 Feb; 1(4):176-7. PubMed ID: 7043219
    [No Abstract]   [Full Text] [Related]  

  • 106. When applied to facial skin, does estrogen ointment have systemic effects?
    Kainz C; Gitsch G; Stani J; Breitenecker G; Binder M; Schmidt JB
    Arch Gynecol Obstet; 1993; 253(2):71-4. PubMed ID: 8215610
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Assessing inflammation and epithelial integrity in vaginal product research. Proceedings of a workshop. November 19-21, 2003. Dominican Republic.
    J Acquir Immune Defic Syndr; 2004 Oct; 37 Suppl 3():S143-200. PubMed ID: 16479634
    [No Abstract]   [Full Text] [Related]  

  • 108. [Principles of estriol therapy].
    Patt V; Korte W
    Arch Gynakol; 1971 Jun; 211(1):206-8. PubMed ID: 5108848
    [No Abstract]   [Full Text] [Related]  

  • 109. The effects of oral estriol on the endometrium in postmenopausal women.
    Scialli A; Fugh-Berman A
    Maturitas; 2003 Jun; 45(2):147; author reply 149. PubMed ID: 12858852
    [No Abstract]   [Full Text] [Related]  

  • 110. Influence of food on oestriol blood levels.
    Englund D; Heimer G; Johansson ED
    Maturitas; 1984 Jul; 6(1):71-5. PubMed ID: 6472128
    [No Abstract]   [Full Text] [Related]  

  • 111. Ovarian epithelial cancer and chemical carcinogenesis.
    Venter PF
    Gynecol Oncol; 1981 Dec; 12(3):281-5. PubMed ID: 7308865
    [No Abstract]   [Full Text] [Related]  

  • 112. [Chemical burns after use of a vaginal tightening stick: an unknown adverse effect of a popular international product].
    ArrudaSoares D; van Oostwaard MF; van der Klift EM
    Ned Tijdschr Geneeskd; 2021 Dec; 166():. PubMed ID: 35138699
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Ovestin vaginal cream and suppositories for the treatment of menopausal vaginal atrophy.
    Trevoux R; van der Velden WH; Popović D
    Reproduccion; 1982; 6(2):101-6. PubMed ID: 7141096
    [TBL] [Abstract][Full Text] [Related]  

  • 114. The treatment of postmenopausal vaginal atrophy with Ovestin vaginal cream or suppositories: clinical, endocrinological and safety aspects.
    Kicovic PM; Cortes-Prieto J; Milojević S; Haspels AA; Aljinovic A
    Maturitas; 1980 Dec; 2(4):275-82. PubMed ID: 6785553
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Estriol: safety and efficacy.
    Head KA
    Altern Med Rev; 1998 Apr; 3(2):101-13. PubMed ID: 9577246
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Transvaginal estriol administration in postmenopausal women: a double blind comparative study of two different doses.
    Bottiglione F; Volpe A; Esposito G; Aloysio DD
    Maturitas; 1995 Nov; 22(3):227-32. PubMed ID: 8746880
    [TBL] [Abstract][Full Text] [Related]  

  • 117. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.
    Raz R; Stamm WE
    N Engl J Med; 1993 Sep; 329(11):753-6. PubMed ID: 8350884
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Biochemical and histological effects of vaginal estriol and estradiol applications on the endometrium, myometrium and vagina of postmenopausal women.
    van Haaften M; Donker GH; Sie-Go DM; Haspels AA; Thijssen JH
    Gynecol Endocrinol; 1997 Jun; 11(3):175-85. PubMed ID: 9209898
    [TBL] [Abstract][Full Text] [Related]  

  • 119. A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy.
    Henriksson L; Stjernquist M; Boquist L; Alander U; Selinus I
    Am J Obstet Gynecol; 1994 Sep; 171(3):624-32. PubMed ID: 8092207
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Local oestrogen for vaginal atrophy in postmenopausal women.
    Lethaby A; Ayeleke RO; Roberts H
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD001500. PubMed ID: 27577677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.